Mona Hegazy

564 total citations
30 papers, 435 citations indexed

About

Mona Hegazy is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mona Hegazy has authored 30 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 9 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mona Hegazy's work include Liver Disease Diagnosis and Treatment (14 papers), Diet, Metabolism, and Disease (6 papers) and Liver Disease and Transplantation (4 papers). Mona Hegazy is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Diet, Metabolism, and Disease (6 papers) and Liver Disease and Transplantation (4 papers). Mona Hegazy collaborates with scholars based in Egypt, United States and Australia. Mona Hegazy's co-authors include E.S. Sous, Michael M. Engelgau, William H. Herman, Ross J. Brechner, Trevor Thompson, Scott Wetterhall, Ann Malarcher, Paula Smith, Frank DeStefano and Amira Badran and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of the Rheumatic Diseases.

In The Last Decade

Mona Hegazy

27 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mona Hegazy Egypt 9 190 139 71 66 64 30 435
Carlo Acierno Italy 13 180 0.9× 190 1.4× 92 1.3× 91 1.4× 105 1.6× 30 610
Coimbatore Subramanian Shanthi Rani India 9 203 1.1× 79 0.6× 32 0.5× 43 0.7× 33 0.5× 15 384
Ali Jawa Pakistan 13 311 1.6× 60 0.4× 53 0.7× 107 1.6× 46 0.7× 35 714
E.S. Sous United States 8 412 2.2× 99 0.7× 111 1.6× 95 1.4× 103 1.6× 8 616
Antonio Rodríguez‐Poncelas Spain 12 208 1.1× 64 0.5× 108 1.5× 36 0.5× 114 1.8× 36 503
J. Flack Australia 10 226 1.2× 117 0.8× 15 0.2× 51 0.8× 24 0.4× 13 507
Coimbatore Subramanian Shanthirani India 9 183 1.0× 167 1.2× 21 0.3× 205 3.1× 18 0.3× 11 707
Nischit Baral Nepal 15 222 1.2× 88 0.6× 11 0.2× 55 0.8× 12 0.2× 68 540
Hakima Hannachi United States 7 254 1.3× 119 0.9× 11 0.2× 76 1.2× 15 0.2× 14 463
Armin Rajab Iran 11 97 0.5× 72 0.5× 19 0.3× 27 0.4× 13 0.2× 29 298

Countries citing papers authored by Mona Hegazy

Since Specialization
Citations

This map shows the geographic impact of Mona Hegazy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Hegazy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Hegazy more than expected).

Fields of papers citing papers by Mona Hegazy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Hegazy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Hegazy. The network helps show where Mona Hegazy may publish in the future.

Co-authorship network of co-authors of Mona Hegazy

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Hegazy. A scholar is included among the top collaborators of Mona Hegazy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Hegazy. Mona Hegazy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hegazy, Mona, et al.. (2025). Metabolic dysfunction-associated steatotic liver disease and omega-6 polyunsaturated fatty acids: Friends or foes. World Journal of Hepatology. 17(3). 102286–102286. 1 indexed citations
2.
3.
Soliman, Amin Roshdy, et al.. (2024). Dietary recommendations for people with diabetes in special situations: a position statement report by Arabic Association for the Study of Diabetes and metabolism (AASD). Journal of Health Population and Nutrition. 43(1). 139–139. 1 indexed citations
4.
Okasha, Hussein, et al.. (2024). Study of non-alcoholic fatty pancreatic disease among the Egyptian population and the value of serum fatty acid binding protein-1 (FABP-1) as a non-invasive biomarker. Clinics and Research in Hepatology and Gastroenterology. 48(6). 102364–102364. 1 indexed citations
5.
Hegazy, Mona, et al.. (2024). Non-alcoholic fatty liver disease related knowledge among a sample of Egyptians: an exploratory cross-sectional study. Frontiers in Public Health. 11. 1290842–1290842. 3 indexed citations
6.
Hegazy, Mona, et al.. (2023). Beneficial role of healthy eating Index-2015 score & physical activity on COVID-19 outcomes. BMC Nutrition. 9(1). 113–113. 4 indexed citations
7.
Hegazy, Mona, et al.. (2021). Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD Severity. Diabetes Metabolic Syndrome and Obesity. Volume 14. 2247–2254. 6 indexed citations
8.
Hegazy, Mona, et al.. (2020). Effect of Nursing Guidelines Regarding Safety Measures on Occurrence of Injuries among Adolescents with Multiple Sclerosis. Egyptian Journal of Health Care. 11(1). 1067–1084.
9.
Hegazy, Mona, et al.. (2020). <p>Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 3861–3872. 28 indexed citations
10.
Hegazy, Mona, et al.. (2020). <p>Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 297–305. 12 indexed citations
11.
Hegazy, Mona, et al.. (2019). Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link?. Journal of Diabetes Research. 2019. 1–7. 18 indexed citations
12.
Tousson, Ehab, et al.. (2014). The Effect of L-carnitine on Amethopterin-induced Toxicity in Rat Large Intestine. 2(3). 55–63. 10 indexed citations
13.
Hegazy, Mona, et al.. (2014). Serum Resistin Level and Its Receptor Gene Expression in Liver Biopsy as Predictors for the Severity of Nonalcoholic Fatty Liver Disease. Euroasian Journal of Hepato-Gastroenterology. 4(2). 59–62. 2 indexed citations
14.
Hegazy, Mona, et al.. (2012). Liver ultrasound scanning in the detection of hepatic steatosis and fibrosis in NASH patients. SHILAP Revista de lepidopterología. 24(2). 27–31. 5 indexed citations
15.
El‐Ghazaly, Mona A., et al.. (2011). Management of Arthritis by Exposure to Low-Dose Ionizing Radiation. 24(2). 297–308. 1 indexed citations
16.
Hegazy, Mona, et al.. (2011). Egyptian experience of reliability of 4T's score in diagnosis of heparin induced thrombocytopenia syndrome. Blood Coagulation & Fibrinolysis. 22(8). 701–705. 8 indexed citations
17.
Hegazy, Mona, et al.. (2011). Association of the Leu72Met polymorphism of the ghrelin gene and ghrelin level with type 2 diabetes mellitus and obesity. Comparative Clinical Pathology. 21(6). 1493–1499. 1 indexed citations
18.
Penman, Alan D., Jinan Saaddine, Mona Hegazy, et al.. (1998). Screening for diabetic retinopathy: the utility of nonmydriatic retinal photography in Egyptian adults. Diabetic Medicine. 15(9). 783–787. 26 indexed citations
19.
Herman, William H., Ronald E. Aubert, Michael M. Engelgau, et al.. (1998). Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabetic Medicine. 15(12). 1045–1051. 93 indexed citations
20.
Thompson, Trevor, Michael M. Engelgau, Mona Hegazy, et al.. (1996). The Onset of NIDDM and its Relationship to Clinical Diagnosis in Egyptian Adults. Diabetic Medicine. 13(4). 337–340. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlo Acierno Breakdown of academic impact, for papers by Coimbatore Subramanian Shanthi Rani Breakdown of academic impact, for papers by Ali Jawa Breakdown of academic impact, for papers by E.S. Sous Breakdown of academic impact, for papers by Antonio Rodríguez‐Poncelas Breakdown of academic impact, for papers by J. Flack Breakdown of academic impact, for papers by Coimbatore Subramanian Shanthirani Breakdown of academic impact, for papers by Nischit Baral Breakdown of academic impact, for papers by Hakima Hannachi Breakdown of academic impact, for papers by Armin Rajab
Rankless by CCL
2026